CREB5
Basic information
Region (hg38): 7:28299321-28825894
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the CREB5 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 0 | |||||
missense | 23 | 23 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 23 | 0 | 0 |
Variants in CREB5
This is a list of pathogenic ClinVar variants found in the CREB5 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
7-28492846-G-T | Vascular endothelial growth factor (VEGF) inhibitor response | association (-) | ||
7-28494906-C-T | not specified | Uncertain significance (Dec 15, 2023) | ||
7-28570372-C-T | not specified | Uncertain significance (Feb 15, 2023) | ||
7-28570402-C-T | not specified | Uncertain significance (Sep 12, 2023) | ||
7-28570410-G-A | not specified | Uncertain significance (Aug 01, 2022) | ||
7-28570438-T-A | not specified | Uncertain significance (May 23, 2023) | ||
7-28570445-C-G | not specified | Uncertain significance (Feb 01, 2023) | ||
7-28570486-C-T | not specified | Uncertain significance (Dec 09, 2023) | ||
7-28570494-A-T | not specified | Uncertain significance (Jan 23, 2024) | ||
7-28570527-C-T | not specified | Uncertain significance (Aug 17, 2021) | ||
7-28724229-G-A | not specified | Uncertain significance (Dec 19, 2023) | ||
7-28724292-C-A | not specified | Uncertain significance (Feb 09, 2023) | ||
7-28724312-A-G | not specified | Uncertain significance (Aug 10, 2023) | ||
7-28804250-A-G | not specified | Uncertain significance (Feb 22, 2023) | ||
7-28804263-G-T | not specified | Uncertain significance (May 08, 2024) | ||
7-28804281-T-C | not specified | Uncertain significance (Dec 05, 2022) | ||
7-28804290-G-A | not specified | Uncertain significance (Apr 11, 2023) | ||
7-28804329-C-T | not specified | Uncertain significance (Oct 25, 2023) | ||
7-28804386-C-T | not specified | Uncertain significance (Dec 28, 2023) | ||
7-28804403-C-A | not specified | Uncertain significance (Jul 20, 2022) | ||
7-28809250-G-T | not specified | Uncertain significance (Mar 13, 2023) | ||
7-28809257-G-T | not specified | Uncertain significance (Dec 14, 2022) | ||
7-28809284-A-G | not specified | Uncertain significance (May 01, 2024) | ||
7-28809352-G-T | not specified | Uncertain significance (Jan 23, 2024) | ||
7-28818111-A-G | not specified | Uncertain significance (Feb 27, 2024) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
CREB5 | protein_coding | protein_coding | ENST00000357727 | 11 | 526572 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.223 | 0.777 | 125737 | 0 | 11 | 125748 | 0.0000437 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 1.61 | 230 | 310 | 0.742 | 0.0000177 | 3390 |
Missense in Polyphen | 47 | 73.847 | 0.63645 | 825 | ||
Synonymous | 0.181 | 112 | 114 | 0.979 | 0.00000716 | 955 |
Loss of Function | 3.48 | 6 | 24.7 | 0.243 | 0.00000114 | 272 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.0000593 | 0.0000593 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.00 | 0.00 |
Finnish | 0.000140 | 0.000139 |
European (Non-Finnish) | 0.0000355 | 0.0000352 |
Middle Eastern | 0.00 | 0.00 |
South Asian | 0.0000654 | 0.0000653 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Binds to the cAMP response element and activates transcription. {ECO:0000269|PubMed:8378084}.;
- Pathway
- PI3K-Akt signaling pathway - Homo sapiens (human);Cortisol synthesis and secretion - Homo sapiens (human);Relaxin signaling pathway - Homo sapiens (human);Aldosterone synthesis and secretion - Homo sapiens (human);Dopaminergic synapse - Homo sapiens (human);Insulin resistance - Homo sapiens (human);Cushing,s syndrome - Homo sapiens (human);Thyroid hormone synthesis - Homo sapiens (human);Vasopressin-regulated water reabsorption - Homo sapiens (human);Huntington,s disease - Homo sapiens (human);TNF signaling pathway - Homo sapiens (human);AMPK signaling pathway - Homo sapiens (human);Thermogenesis - Homo sapiens (human);Glucagon signaling pathway - Homo sapiens (human);Adrenergic signaling in cardiomyocytes - Homo sapiens (human);Prostate cancer - Homo sapiens (human);Longevity regulating pathway - Homo sapiens (human);cAMP signaling pathway - Homo sapiens (human);Estrogen signaling pathway - Homo sapiens (human);Amphetamine addiction - Homo sapiens (human);Viral carcinogenesis - Homo sapiens (human);Hepatitis B - Homo sapiens (human);cGMP-PKG signaling pathway - Homo sapiens (human);Cholinergic synapse - Homo sapiens (human);Alcoholism - Homo sapiens (human);Cocaine addiction - Homo sapiens (human);Insulin secretion - Homo sapiens (human);Human papillomavirus infection - Homo sapiens (human);Focal Adhesion-PI3K-Akt-mTOR-signaling pathway;PI3K-Akt Signaling Pathway
(Consensus)
Intolerance Scores
- loftool
- 0.217
- rvis_EVS
- -0.67
- rvis_percentile_EVS
- 15.62
Haploinsufficiency Scores
- pHI
- 0.776
- hipred
- Y
- hipred_score
- 0.746
- ghis
- 0.574
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.883
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Creb5
- Phenotype
- integument phenotype (the observable morphological and physiological characteristics of the skin and its associated structures, such as the hair, nails, sweat glands, sebaceous glands and other secretory glands that are manifested through development and lifespan); adipose tissue phenotype (the observable morphological and physiological characteristics of mammalian fat tissue that are manifested through development and lifespan); homeostasis/metabolism phenotype; cellular phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span);
Gene ontology
- Biological process
- regulation of transcription by RNA polymerase II;transcription by RNA polymerase II;positive regulation of transcription, DNA-templated
- Cellular component
- nucleus;extracellular exosome
- Molecular function
- DNA-binding transcription factor activity, RNA polymerase II-specific;DNA binding;DNA-binding transcription factor activity;protein binding;metal ion binding